Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertension.

MLA

Garcia-Tsao, Guadalupe, et al. “Randomized Placebo-Controlled Trial of Emricasan for Non-Alcoholic Steatohepatitis-Related Cirrhosis with Severe Portal Hypertension.” Journal of Hepatology, vol. 72, no. 5, May 2020, pp. 885–95. EBSCOhost, https://doi.org/10.1016/j.jhep.2019.12.010.

APA

Garcia-Tsao, G., Bosch, J., Kayali, Z., Harrison, S. A., Abdelmalek, M. F., Lawitz, E., Satapathy, S. K., Ghabril, M., Shiffman, M. L., Younes, Z. H., Thuluvath, P. J., Berzigotti, A., Albillos, A., Robinson, J. M., Hagerty, D. T., Chan, J. L., & Sanyal, A. J. (2020). Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertension. Journal of Hepatology, 72(5), 885–895. https://doi.org/10.1016/j.jhep.2019.12.010

Chicago

Garcia-Tsao, Guadalupe, Jaime Bosch, Zeid Kayali, Stephen A Harrison, Manal F Abdelmalek, Eric Lawitz, Sanjaya K Satapathy, et al. 2020. “Randomized Placebo-Controlled Trial of Emricasan for Non-Alcoholic Steatohepatitis-Related Cirrhosis with Severe Portal Hypertension.” Journal of Hepatology 72 (5): 885–95. doi:10.1016/j.jhep.2019.12.010.